Improving outcomes of acute kidney injury using mouse renal progenitor cells alone or in combination with erythropoietin or suramin

INTRODUCTION: So far, no effective therapy is available for acute kidney injury (AKI), a common and serious complication with high morbidity and mortality. Interest has recently been focused on the potential therapeutic effect of mouse adult renal progenitor cells (MRPC), erythropoietin (EPO) and su...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiao, Zhao, Li, Lu, Guodong, Ge, Junke, Zhao, Yalin, Zu, Shulu, Yuan, Mingzhen, Liu, Yuqiang, Kong, Feng, Xiao, Zhiying, Zhao, Shengtian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706945/
https://www.ncbi.nlm.nih.gov/pubmed/23777889
http://dx.doi.org/10.1186/scrt225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706945/
https://www.ncbi.nlm.nih.gov/pubmed/23777889
http://dx.doi.org/10.1186/scrt225

Ejemplares similares